We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$156M
AUM Growth
-$11.1M
Cap. Flow
-$22.2M
Cap. Flow %
-14.27%
Top 10 Hldgs %
85.77%
Holding
76
New
22
Increased
15
Reduced
20
Closed
15

Top Buys

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$18.3M
2
XP icon
XP
XP
+$11.3M
3
NGD
New Gold Inc
NGD
+$5.22M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$4.38M
5
INTR icon
Inter&Co
INTR
+$1.26M

Sector Composition

Rank Sector Weight
1 Financials 32.7%
2 Healthcare 12.69%
3 Technology 11.38%
4 Materials 4.47%
5 Energy 0.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XP icon
1
XP
XP
$8.43B
$29.9M 19.21%
1,165,000
+451,836
+63% +$11.3M
STNE icon
2
StoneCo
STNE
$2.67B
$17.7M 11.38%
+1,065,700
New +$18.3M
NU icon
3
Nu Holdings
NU
$67.8B
$17.4M 11.19%
1,460,000
-1,517,959
-51% -$15.5M
NGD
4
DELISTED
New Gold Inc
NGD
$6.5M 4.18%
+3,823,527
New +$5.22M
RYTM icon
5
Rhythm Pharmaceuticals
RYTM
$7.31B
$4.58M 2.95%
105,814
+100,126
+1,760% +$4.38M
INCY icon
6
Incyte
INCY
$25.8B
$1.79M 1.15%
31,440
+134
+0.4% +$8.04K
LLY icon
7
Eli Lilly
LLY
$1.08T
$1.69M 1.09%
2,177
-162
-7% -$115K
ONC
8
BeOne Medicines Ltd
ONC
$33.9B
$1.64M 1.05%
10,471
+626
+6% +$101K
INTR icon
9
Inter&Co
INTR
$2.39B
$1.31M 0.84%
+229,172
New +$1.26M
SPGI icon
10
S&P Global
SPGI
$124B
$1.28M 0.82%
3,000
+1,900
+173% +$824K
UNH icon
11
UnitedHealth
UNH
$382B
$1.2M 0.77%
2,430
-696
-22% -$354K
TMO icon
12
Thermo Fisher Scientific
TMO
$214B
$816K 0.52%
1,404
-469
-25% -$263K
ISRG icon
13
Intuitive Surgical
ISRG
$127B
$712K 0.46%
1,785
-361
-17% -$136K
ACAD icon
14
Acadia Pharmaceuticals
ACAD
$4.51B
$680K 0.44%
36,755
+645
+2% +$16K
GDX icon
15
VanEck Gold Miners ETF
GDX
$22.5B
$667K 0.43%
21,093
-21,091
-50% -$599K
MRK icon
16
Merck
MRK
$322B
$667K 0.43%
5,053
-1,122
-18% -$138K
ELV icon
17
Elevance Health
ELV
$81.5B
$614K 0.39%
1,184
-5
-0.4% -$2.49K
SYK icon
18
Stryker
SYK
$135B
$612K 0.39%
1,709
-95
-5% -$32K
J icon
19
Jacobs Solutions
J
$16B
$556K 0.36%
4,372
+1,973
+82% +$231K
YPF icon
20
YPF
YPF
$19.7B
$495K 0.32%
+25,000
New +$434K
DHR icon
21
Danaher
DHR
$138B
$470K 0.3%
1,883
-936
-33% -$228K
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$123B
$442K 0.28%
1,058
-434
-29% -$183K
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$11.9B
$369K 0.24%
4,225
+1,093
+35% +$97.8K
MDGL icon
24
Madrigal Pharmaceuticals
MDGL
$12.6B
$356K 0.23%
1,333
+28
+2% +$6.6K
ARGX icon
25
argenx
ARGX
$55.2B
$353K 0.23%
896
-100
-10% -$38.7K

Similar funds

JGP Global Gestao de Recursos's Q1 2024 Portfolio in Review

As of Q1 2024, JGP Global Gestao de Recursos held 76 positions worth $156M, down 6.7% from $167M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $22.2M in Q1 2024, closing 15 positions and reducing 20 holdings. Its most notable exit was Boyd Gaming, an estimated $64.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

Against the trend, JGP Global Gestao de Recursos opened a new position in StoneCo worth $17.7M.

  • JGP Global Gestao de Recursos's largest Q1 2024 buy was StoneCo: 1,065,700 shares worth $17.7M.
  • JGP Global Gestao de Recursos added most to XP in Q1 2024, an estimated $11.3M increase.
  • JGP Global Gestao de Recursos's biggest Q1 2024 reduction was Nu Holdings, cutting an estimated $15.5M.
  • JGP Global Gestao de Recursos fully exited Boyd Gaming in Q1 2024, selling an estimated $64.3M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 86% of its $156M portfolio in Q1 2024.
  • JGP Global Gestao de Recursos opened 22 new positions and closed 15 in Q1 2024.
  • JGP Global Gestao de Recursos's portfolio value fell 6.7% quarter-over-quarter to $156M.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2024, filed 9 May 2024.